BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28056882)

  • 1. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
    Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
    BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
    Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
    Hasmim M; Bruno S; Azzi S; Gallerne C; Michel JG; Chiabotto G; Lecoz V; Romei C; Spaggiari GM; Pezzolo A; Pistoia V; Angevin E; Gad S; Ferlicot S; Messai Y; Kieda C; Clay D; Sabatini F; Escudier B; Camussi G; Eid P; Azzarone B; Chouaib S
    Oncotarget; 2016 Mar; 7(13):15507-24. PubMed ID: 26551931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triiodothyronine regulates cell growth and survival in renal cell cancer.
    Czarnecka AM; Matak D; Szymanski L; Czarnecka KH; Lewicki S; Zdanowski R; Brzezianska-Lasota E; Szczylik C
    Int J Oncol; 2016 Oct; 49(4):1666-78. PubMed ID: 27632932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neovascularity as a prognostic marker in renal cell carcinoma.
    Bauman TM; Huang W; Lee MH; Abel EJ
    Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
    Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
    Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a tumor-initiating stem cell population in human renal carcinomas.
    Bussolati B; Bruno S; Grange C; Ferrando U; Camussi G
    FASEB J; 2008 Oct; 22(10):3696-705. PubMed ID: 18614581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
    Zhang XF; Weng DS; Pan K; Zhou ZQ; Pan QZ; Zhao JJ; Tang Y; Jiang SS; Chen CL; Li YQ; Zhang HX; Chang AE; Wicha MS; Zeng YX; Li Q; Xia JC
    Mol Carcinog; 2017 Nov; 56(11):2499-2511. PubMed ID: 28621442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Cell Culture Model Utilization in Renal Carcinoma Cancer Stem Cell Research.
    Maliszewska-Olejniczak K; Brodaczewska KK; Bielecka ZF; Czarnecka AM
    Methods Mol Biol; 2018; 1817():47-66. PubMed ID: 29959702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
    Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
    Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases.
    Pivovarcikova K; Peckova K; Martinek P; Montiel DP; Kalusova K; Pitra T; Hora M; Skenderi F; Ulamec M; Daum O; Rotterova P; Ondic O; Dubova M; Curik R; Dunatov A; Svoboda T; Michal M; Hes O
    Virchows Arch; 2016 Jul; 469(1):71-80. PubMed ID: 27072821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells.
    Hu J; Guan W; Liu P; Dai J; Tang K; Xiao H; Qian Y; Sharrow AC; Ye Z; Wu L; Xu H
    Stem Cell Reports; 2017 Aug; 9(2):464-477. PubMed ID: 28793246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma.
    Oladejo M; Nguyen HM; Seah H; Datta A; Wood LM
    Cancer Immunol Immunother; 2023 Jun; 72(6):1633-1646. PubMed ID: 36586013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.
    Grange C; Tapparo M; Collino F; Vitillo L; Damasco C; Deregibus MC; Tetta C; Bussolati B; Camussi G
    Cancer Res; 2011 Aug; 71(15):5346-56. PubMed ID: 21670082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.